Jerald P. Radich

55.2k citations

394 papers · 22.0k indexed · 9 hit papers · h-index 77

Impact in

Hematology top 0.01%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 344
- Chronic Myeloid Leukemia Treatments 255
- Acute Myeloid Leukemia Research 136
- Hematopoietic Stem Cell Transplantation 38
Genetics 208
- Chronic Lymphocytic Leukemia Research 176
- Myeloproliferative Neoplasms: Diagnosis and Treatment 33

Co-authors: Derek L. Stirewalt Timothy P. Hughes Andreas Hochhaus Frederick R. Appelbaum Susan Branford Brian Druker John M. Goldman Richard A. Larson
Journals: Blood (151 papers)Journal of Clinical Oncology (18 papers)Biology of Blood and Marrow Transplantation (16 papers)Leukemia (13 papers)Journal of the National Comprehensive Cancer Network (10 papers)
Partner nations: United States Germany Australia

In The Last Decade

Jerald P. Radich

380 papers receiving 21.5k citations

Hit Papers

9 papers align trajectories log scale

Management of chronic myeloid leukemia in 2023 – common ground and common sense 2023 · 73 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Blood Cancer Journal
2017 JAMA Oncology
2017 New England Journal of Medicine
2009 Leukemia
2009 Blood
2009 Journal of Clinical Oncology
2003 Nature reviews. Cancer
2003 Nature reviews. Cancer
2003 New England Journal of Medicine

Peers

Countries citing papers authored by Jerald P. Radich

Since Specialization

Citations

This map shows the geographic impact of Jerald P. Radich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerald P. Radich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerald P. Radich more than expected).

Fields of papers citing papers by Jerald P. Radich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerald P. Radich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerald P. Radich. The network helps show where Jerald P. Radich may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerald P. Radich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerald P. Radich Line = papers co-authored together Jerald P. Radich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing Bone Marrow Transplantation ·Elizabeth F. Krakow, Nathan Lee, Isaac Jenkins, Olga Sala‐Torra, Lan Beppu, Jerald P. Radich, Bryce Fukuda, Brenda M. Sandmaier, Cecilia C.S. Yeung, Ivana Božić	2025	0
2	Recommendations from the AML molecular MRD expert advisory board Leukemia ·Stuart Scott, Alison S. Devonshire, Richard Dillon, Christian Thiede, Nicholas C.P. Cross, Helen White, Leandro Lo Cascio, Katya Mokretar, Nicola Potter, Christopher S. Hourigan, Jerald P. Radich, Adam Corner, Véronique Laloux, Gemma Halliday, Daniel D. Dilks, Tom Morrison, Katelyn Gilmour, Ashley Cartwright, Liam Whitby	2024	2
3	European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia Leukemia ·Nicholas C.P. Cross, Thomas Ernst, Susan Branford, Jean‐Michel Cayuela, Michael W. Deininger, Alice Fabarius, Dennis Dong Hwan Kim, Kateřina Machová Poláková, Jerald P. Radich, Rüdiger Hehlmann, Andreas Hochhaus, Jane F. Apperley, Simona Soverini	2023	37
4	Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies Haematologica ·David W. Woolston, Nathan D. Lee, Mazyar Shadman, Elena Latorre‐Esteves, Xin Ray Tee, Jeanne Fredrickson, Brendan F. Kohrn, Chaitra S. Ujjani, Ashley M. Eckel, Brian G. Till, Min Fang, Jerald P. Radich, Ivana Božić, Rosa Ana Risques, Cecilia C.S. Yeung	2023	4
5	Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia Leukemia & lymphoma ·Ryan D. Cassaday, Lucas C. Zarling, Kelsey‐Leigh A. Garcia, Olga Sala‐Torra, Philip A. Stevenson, Christen H. Martino, Yajuan J. Liu, Min Fang, Mary‐Elizabeth M. Percival, Anna B. Halpern, Pamela S. Becker, Vivian G. Oehler, Andrei R. Shustov, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Jerald P. Radich, Lorinda Soma, Elihu H. Estey	2023	4
6	A graphical, interactive and GPU-enabled workflow to process long-read sequencing data BMC Genomics ·Shishir Reddy, Ling-Hong Hung, Olga Sala‐Torra, Jerald P. Radich, Cecilia C.S. Yeung, Ka Yee Yeung	2021	7
7	Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies Hematological Oncology ·Tariq I. Mughal, Naveen Pemmaraju, Bethan Psaila, Jerald P. Radich, Prithviraj Bose, Thomas Lion, Jean‐Jacques Kiladjian, Raajit K. Rampal, Tania Jain, Srdnan Verstovsek, Abdulraheem Yacoub, Jörge E. Cortes, Ruben A. Mesa, Giuseppe Saglio, Richard A. Van Etten	2020	1
8	Accrual Barriers and Detection of Early Toxicity Signal in Older Less-Fit Patients Treated with Azacitidine and Nivolumab for Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) in the SWOG 1612 Platform Randomized Phase II/III Clinical Trial Blood ·Annette E. Hay, Sarit Assouline, Roland B. Walter, Richard F. Little, Anna Moseley, Sperling M Gail, Annie Im, James M. Foran, Jerald P. Radich, Min Fang, Megan Othus, Harry P. Erba, Laura C. Michaelis	2019	7
9	Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis Cancer Research ·Julia E. Maxson, Melissa L. Abel, Jinhua Wang, Xianming Deng, Sina Reckel, Samuel B. Luty, Huahang Sun, Julie Gorenstein, Seamus B. Hughes, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, Jerald P. Radich, Oliver Hantschel, Richard E. Middleton, Nathanael S. Gray, Brian Druker, Jeffrey Tyner	2016	26
10	Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission? Journal of Clinical Oncology ·Daisuke Araki, Brent L. Wood, Megan Othus, Jerald P. Radich, Anna B. Halpern, Yi Zhou, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, Roland B. Walter	2015	258
11	Prognostic Significance of NPM1 Mutations in the Absence of FLT3 –Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report Journal of Clinical Oncology ·Fabiana Ostronoff, Megan Othus, Michelle Lazenby, Elihu H. Estey, Frederick R. Appelbaum, Anna Evans, John E. Godwin, Amanda Gilkes, Kenneth J. Kopecky, Alan K. Burnett, Alan F. List, Min Fang, Vivian G. Oehler, Stephen H. Petersdorf, Era L. Pogosova‐Agadjanyan, Jerald P. Radich, Cheryl L. Willman, Soheil Meshinchi, Derek L. Stirewalt	2015	96
12	Sequencing small genomic targets with high efficiency and extreme accuracy Nature Methods ·Michael W. Schmitt, Edward Fox, Marc J. Prindle, Kate S. Reid-Bayliss, Lawrence D. True, Jerald P. Radich, Lawrence A. Loeb	2015	110
13	Multi-Center US Intergroup Study of Intensive Chemotherapy Plus Dasatinib Followed By Allogeneic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60 Blood ·Farhad Ravandi, Megan Othus, Susan O’Brien, Stephen J. Forman, Chul S. Ha, Jeffrey Y.C. Wong, Martin S. Tallman, Elisabeth Paietta, Janis Racevskis, Geoffrey L. Uy, Uma Borate, Partow Kebriaei, Laura Kingsbury, Hagop M. Kantarjian, Jerald P. Radich, Harry P. Erba, Frederick R. Appelbaum	2015	11
14	Transferred WT1-Reactive CD8 ⁺ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients Science Translational Medicine ·Aude G. Chapuis, Gunnar B. Ragnarsson, Hieu Nguyen, Colette Chaney, Jeffrey S. Pufnock, Thomas M. Schmitt, Natalie Duerkopp, Ilana M. Roberts, Galina Pogosov, William Ho, Sebastian Ochsenreither, Matthias Wölfl, Merav Bar, Jerald P. Radich, Cassian Yee, Philip D. Greenberg	2013	242
15	BCR–ABL Transcript Dynamics Support the Hypothesis That Leukemic Stem Cells Are Reduced during Imatinib Treatment Clinical Cancer Research ·Andrew M. Stein, Dean Bottino, Vijay Modur, Susan Branford, Jaspal Kaeda, John M. Goldman, Timothy P. Hughes, Jerald P. Radich, Andreas Hochhaus	2011	32
16	Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up Blood ·Hagop M. Kantarjian, Jörge E. Cortes, Dong‐Wook Kim, Pedro Enrique Dorlhiac‐Llacer, Ricardo Pasqüini, John F. DiPersio, Martin Müller, Jerald P. Radich, H. Jean Khoury, Н Д Хорошко, M. Brigid Bradley‐Garelik, Chao Zhu, Martin S. Tallman	2009	127
17	Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Journal of Clinical Oncology ·Timothy P. Hughes, Giuseppe Saglio, Susan Branford, Simona Soverini, Dong‐Wook Kim, Martin C. Müller, Giovanni Martinelli, Jörge E. Cortes, Lan Beppu, Enrico Gottardi, Dong‐Ho Kim, Philipp Erben, Yaping Shou, Md Ariful Haque, Neil J. Gallagher, Jerald P. Radich, Andreas Hochhaus	2009	236
18	Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning Journal of Clinical Oncology ·Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, Michael B. Maris, Judith A. Shizuru, Richard T. Maziarz, Edward Agura, Thomas R. Chauncey, Michael A. Pulsipher, Peter A. McSweeney, James C. Wade, Benedetto Bruno, Amelia Langston, Jerald P. Radich, Dietger Niederwieser, Karl G. Blume, Rainer Storb, David G. Maloney	2008	182
19	Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia Hematology ·Derek L. Stirewalt, Jerald P. Radich	2000	7
20	The detection and significance of minimal residual disease in chronic myeloid leukemia. PubMed ·Jerald P. Radich	2000	7

About Jerald P. Radich

Jerald P. Radich is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 394 papers that have together received 22.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (255 papers), Chronic Lymphocytic Leukemia Research (176 papers), Acute Myeloid Leukemia Research (136 papers), Eosinophilic Disorders and Syndromes (94 papers), Acute Lymphoblastic Leukemia research (88 papers), Hematopoietic Stem Cell Transplantation (38 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers) and Lymphoma Diagnosis and Treatment (25 papers). The work is most often cited by research in Hematology (16.8k citations), Genetics (10.1k citations), Rheumatology (5.4k citations), Public Health, Environmental and Occupational Health (4.3k citations) and Oncology (3.3k citations). Jerald P. Radich has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Derek L. Stirewalt, Timothy P. Hughes, Andreas Hochhaus, Frederick R. Appelbaum, Susan Branford, Brian Druker, John M. Goldman, Richard A. Larson, François Guilhot and Soheil Meshinchi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, Leukemia and Journal of the National Comprehensive Cancer Network.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact